November 2026 | ISCPh News & Updates
October was an exciting month for the International Society of Cannabis Pharmacists (ISCPh), with participation in three national cannabis research conferences across the United States.
From San Diego to Philadelphia and Orlando, ISCPh contributed to scientific discussions on clinical assessment, medication safety, healthcare professional education, and the evolving role of pharmacists in medical cannabis care.
Together, these conferences highlighted the importance of integrating pharmaceutical expertise into cannabis research, clinical practice, and public health.
National Cannabis Research Conference (NCRC): Standardizing Clinical Assessment
At the National Cannabis Research Conference in San Diego, ISCPh President and Executive Director Dr. Melani Kane presented the Cannabinoid Evaluation and Recommendation System (CbERS), a proposed framework for evaluating therapeutic response and treatment-related adverse effects in patients using medical cannabis.
The presentation addressed the need for more consistent approaches to documenting clinical experiences and supporting individualized treatment decisions.
CbERS is currently being developed for further expert evaluation and validation, with the goal of supporting more interpretable and comparable clinical data.
Read more: Advancing Standardized Assessment of Medical Cannabis Outcomes at NCRC 2026
Mid-Atlantic Cannabis Research Conference (MACRC): Strengthening Professional Education
At MACRC in Philadelphia, Dr. Kane participated in discussions on the evolving role of healthcare professionals in cannabis medicine.
The conversations highlighted the importance of moving beyond general product education to develop practical clinical competencies in medication management, drug-interaction assessment, patient counseling, and safety monitoring.
These priorities align with ISCPh’s ongoing commitment to expanding evidence-based education for healthcare professionals.
Read more: Advancing Healthcare Professional Education in Cannabis Medicine at MACRC 2026
Cannabis Clinical Outcomes Research Conference (CCORC): Building Trust Through Medication Safety
At CCORC in Orlando, Dr. Kane and ISCPh co-founder Christine Roussel presented on the role of pharmacists in strengthening medical cannabis quality, safety, and public health.
Their presentation connected pharmacist involvement with several ISCPh research priorities, including standardized medical cannabis medication histories and the proposed CANN-PIC pharmacist intervention study.
The discussion emphasized that medical cannabis should be integrated into existing medication-safety systems, with appropriate clinical oversight and consistent documentation.
Read more: Building Trust in Medical Cannabis Care at CCORC 2026
Turning Scientific Discussions Into Meaningful Progress
Although each conference addressed different aspects of cannabis medicine, a common theme emerged: advancing cannabis care requires stronger connections between research, clinical practice, education, and regulatory oversight.
ISCPh continues to pursue these priorities through clinical research initiatives, professional education, manuscript development, and collaboration with healthcare professionals and researchers.
We welcome pharmacists, researchers, clinicians, and other interested stakeholders to participate in these efforts as we work toward more standardized, evidence-informed approaches to cannabis medicine.